60df07dbf892e9c5c91f3311ffb2cbd8

EUROLINE COELIAC DISEASE PROFILE (IGG)

BYO COLOMBIA SAS·II·Colombia INVIMA·Expires January 03, 2031

Device classification

Risk class / Clase de Riesgo: II
Product type (Spanish): REACTIVO DIAGNOSTICO
Product type (English): DIAGNOSTIC REAGENT

Registration information

Analysis ID: 60df07dbf892e9c5c91f3311ffb2cbd8
Expire date: January 03, 2031

Authorized company / Fabricante

Name (Spanish): BYO COLOMBIA SAS
Name (English): BYO COLOMBIA SAS

Product use / Uso del Producto

Spanish

DETERMINACIÓN DE LOS DIFERENTES ANALITOS RELACIONADOS CON MUESTRAS PROCEDENTES DEL ORGANISMO HUMANO.

English

DETERMINATION OF THE DIFFERENT ANALYTES RELATED TO SAMPLES FROM THE HUMAN ORGANISM.

About this record

Access comprehensive regulatory information for EUROLINE COELIAC DISEASE PROFILE (IGG) (EUROLINE COELIAC DISEASE PROFILE (IGG)) in the Colombia medical device market through Pure Global AI's free database. This II medical device is registered under INVIMA analysis ID 60df07dbf892e9c5c91f3311ffb2cbd8 and manufactured by BYO COLOMBIA SAS. The device was registered on January 03, 2031.

This page provides complete registration details including product type (DIAGNOSTIC REAGENT), authorised information, and regulatory compliance data from the official Colombia INVIMA medical device database. Pure Global AI offers free access to Colombia's complete medical device registry with bilingual Spanish/English support, helping global MedTech companies navigate INVIMA regulations efficiently.